(Q36918637)

17 August 2017

title

Cost, causes and rates of rehospitalization of preterm infants (English)

1 reference

17 August 2017

0 references

Underwood MA

1

1 reference

17 August 2017

Danielsen B

series ordinal

2

1 reference

17 August 2017

Gilbert WM

series ordinal

3

1 reference

17 August 2017

publication date

23 August 2007

1 reference

17 August 2017

published in

Journal of Perinatology

1 reference

17 August 2017

volume

27

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

614-619

1 reference

The long-term costs of preterm birth and low birth weight: results of a systematic review.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Costs of newborn care in California: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Economic consequences of preterm birth and low birthweight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Economic costs of care in extremely low birthweight infants during the first 2 years of life*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Rehospitalization of extremely low birth weight (ELBW) infants: are there racial/ethnic disparities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Clinical outcomes of near-term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Short-term outcomes of infants born at 35 and 36 weeks gestation: we need to ask more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [ISRCTN44485060].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants: a note of caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Accuracy of obstetric diagnoses and procedures in hospital discharge data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Coding of perineal lacerations and other complications of obstetric care in hospital discharge data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

inferred from DOI database lookup

7 January 2021

based on heuristic

Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

inferred from DOI database lookup

7 January 2021

based on heuristic

Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211801

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.JP.7211801

1 reference

17 August 2017

1 reference